4.1 Upper and Lower Gastrointestinal Bleeding: Resuscitation and Endoscopic Management

Key Takeaways

  • Use the bleeding source, perfusion, ongoing blood loss and cardiovascular status to choose a red cell transfusion strategy. Baveno VII generally targets 70–80 g/L in acute variceal bleeding. Major ongoing haemorrhage requires clinical resuscitation without waiting for a haemoglobin threshold.

  • Use Glasgow-Blatchford before upper endoscopy and the full Rockall score afterwards. For low-risk outpatient triage, ESGE uses a Glasgow-Blatchford score of 0 or 1, and NICE states 0.

  • Forrest Ia and Ib need endoscopic haemostasis. A Forrest IIa visible vessel can receive definitive endoscopic treatment with or without adjunctive adrenaline. Give high-dose PPI after treatment of high-risk ulcers.

  • Start vasoactive treatment and antibiotic prophylaxis when variceal bleeding is suspected. Arrange urgent endoscopy after resuscitation and assess high-risk patients promptly for pre-emptive TIPS.

  • Resuscitate unstable patients with ongoing haematochezia and obtain urgent CTA for suspected lower bleeding. Positive CTA can guide embolisation. Consider an upper source, especially if initial CTA does not identify bleeding.

Last updated: November 2026

Recognise upper and lower GI bleeding

Haematemesis and coffee-ground emesis point to an upper source, proximal to the ligament of Treitz. Melaena is black, tarry stool from digested blood and usually also suggests an upper source. Small-bowel and right colonic bleeding can produce melaena. Iron and bismuth can darken stool without bleeding. Haematochezia is the passage of red or maroon blood per rectum. A colorectal source is usual, but brisk upper GI bleeding can present this way, especially with shock. Small-bowel bleeding has its own diagnostic pathway when initial upper and lower investigation fails to identify the source.

Assess airway, breathing and perfusion and involve senior help early when bleeding is significant. Ask about syncope, retching, liver disease, previous bleeding, alcohol and medicines such as NSAIDs or antithrombotics. Look for tachycardia, hypotension and altered mental state. Measure haemoglobin, platelets, renal profile and coagulation, and request group and screen or crossmatch as indicated. An initially normal haemoglobin can accompany acute haemorrhage. Urea can rise disproportionately to creatinine after an upper bleed, partly from absorbed blood protein and partly from hypoperfusion. Renal disease and other causes of raised urea limit this clue. Irish HSE endoscopy triage directs significant acute upper GI bleeding to emergency review.

HIQA upper GI referral guidance, section 2.5 · BSG-led upper GI bleeding care bundle · ESGE acute lower GI bleeding

Use the correct risk score at the correct time

ToolTimeComponentsDecision
Glasgow-Blatchford Score (GBS)Initial assessment, before endoscopyBlood urea, haemoglobin using sex-specific thresholds, systolic BP, pulse, melaena, syncope, liver disease and cardiac failureEstimates risk of needing hospital treatment or dying. ESGE 2026 identifies GBS ≤1 for possible outpatient care. NICE CG141 uses 0 for considering early discharge.
Full Rockall scoreAfter endoscopyAge, haemodynamic shock, comorbidities, endoscopic diagnosis and stigmata of recent haemorrhageEstimates rebleeding and mortality risk. The clinical part can be calculated before OGD, but does not include lesion or bleeding stigmata.

The GBS ranges from 0 to 23. Use a low score alongside examination, bleeding trajectory, comorbidities and arrangements for timely follow-up. A high score supports urgent assessment but does not prescribe a care setting on its own.

Worked example. A stable patient reports melaena with no syncope or cardiac or liver disease. Blood urea is 5.4 mmol/L, haemoglobin 136 g/L, systolic BP 124 mmHg and pulse 84/min. The only point is for melaena, so GBS is 1. This meets the ESGE low-risk score criterion if the wider assessment and outpatient pathway permit discharge. It does not meet NICE's stated score of 0.

Original Blatchford study · Original Rockall study · Prospective international score comparison · ESGE 2026, table 1 · NICE CG141 risk assessment

Resuscitate and prepare for haemostasis

Use an ABCDE assessment. Give oxygen according to acuity, oxygenation and the local target. In critical shock, high-concentration oxygen can be appropriate initially. Reassess with reliable oximetry and blood gases, including for patients at risk of hypercapnia. Obtain wide-bore IV access and send blood for urgent testing and compatibility. Give an initial isotonic crystalloid bolus for haemodynamic instability while arranging blood if needed. Reassess perfusion after each intervention. If bleeding is major or shock persists, activate the local major haemorrhage pathway and arrange definitive control. Avoid excessive volume, particularly with portal hypertension.

BSG-led upper GI bleeding care bundle · BTS emergency oxygen guideline, recommendation E2 · NICE CG141 resuscitation

Select a red cell transfusion strategy for the bleeding context

In haemodynamically stable acute upper GI bleeding without cardiovascular disease, ESGE uses a threshold of 70 g/L and a post-transfusion target of 70–90 g/L. In acute variceal bleeding, Baveno VII generally targets 70–80 g/L and adjusts for age, cardiovascular disease, haemodynamics and ongoing blood loss. Major ongoing haemorrhage requires physiology-guided resuscitation and local major haemorrhage activation.

ESGE gives a threshold of 80 g/L and a target of at least 100 g/L for its stable upper GI bleeding population with cardiovascular disease. NICE considers 80 g/L with a target of 80–100 g/L for acute coronary syndrome. AABB's 2025 recommendation specific to acute myocardial infarction conditionally favours a more liberal strategy below 100 g/L. In bleeding with active myocardial ischaemia, coordinate the individual decision with the treating teams and local policy.

ESGE 2026 upper GI bleeding update, table 1 · Baveno VII portal hypertension consensus · NICE NG24 red cell recommendations · AABB acute myocardial infarction transfusion guideline

Assess whether antithrombotic reversal is needed

During initial resuscitation, identify the drug, last dose, reason for anticoagulation, renal function, and the severity of ongoing bleeding. Withhold the anticoagulant during significant active haemorrhage and coordinate reversal with the treating team and local major bleeding protocol. Arrange definitive haemostasis in parallel.

  • Warfarin. BSG/ESGE advises IV vitamin K and four-factor prothrombin complex concentrate (PCC) in haemodynamic instability, with fresh frozen plasma if PCC is unavailable. Dose and monitor according to the selected product, baseline INR and local guidance. Avoid delaying endoscopic haemostasis solely to reach a fixed INR.
  • Direct oral anticoagulants. Consider specific reversal for selected unstable patients with a relevant anticoagulant effect. Idarucizumab is the specific dabigatran antidote. Its adult dose is 5 g IV in two consecutive 2.5 g vials, given as infusions or bolus injections according to the product information. Andexanet alfa has an EU indication for life-threatening or uncontrolled bleeding on apixaban or rivaroxaban. That indication excludes edoxaban. Discuss four-factor PCC with haematology if specific reversal is unavailable or unsuitable. Evidence for routine reversal in GI bleeding is limited, and these decisions must account for thrombotic risk.
  • Antiplatelet medicines. For low-dose aspirin used for secondary cardiovascular prevention, ESGE generally advises continuing it or resuming it promptly if interrupted. For dual therapy, involve cardiology early, especially after coronary stenting, to decide which drug to pause and when to restart it. In nonvariceal upper GI bleeding, avoid routine platelet transfusion solely for antiplatelet exposure. Treat clinically important thrombocytopenia or massive blood loss using the bleeding and component protocol. In acute variceal bleeding with uncontrolled haemorrhage, assess haemostatic support case by case.

BSG/ESGE antithrombotic guidance · ESGE 2026 upper GI bleeding update, table 1 · EMA Praxbind product information · EMA Ondexxya indication · ACG/CAG acute GI bleeding guidance

Treat peptic ulcer bleeding by the Forrest appearance

Peptic ulcers are an important cause of nonvariceal upper GI bleeding. Ask about NSAIDs and test for Helicobacter pylori. Endoscopy establishes the lesion and guides haemostasis.

Forrest classEndoscopic appearanceESGE 2026 approach
IaActive arterial spurtingEndoscopic haemostasis. Dilute adrenaline plus a mechanical or contact thermal modality is a standard approach. Selected over-the-scope clips or haemostatic forceps with soft coagulation can be used as monotherapy.
IbActive oozingTreat as active bleeding, using a definitive modality as above.
IIaNonbleeding visible vesselTreat the vessel with thermal, mechanical or sclerosant therapy, alone or with dilute adrenaline. Haemostatic forceps with soft coagulation are another option.
IIbAdherent clotConsider safe clot removal if the endoscopist can manage any exposed bleeding lesion. Treat a high-risk stigma found under the clot.
IIcFlat pigmented spotUsually no endoscopic haemostatic treatment.
IIIClean ulcer baseUsually no endoscopic haemostatic treatment.

Adrenaline injection slows bleeding by vasoconstriction and local tamponade. A clip compresses the vessel, while contact thermal coagulation seals it through pressure and heat. Adrenaline alone is inadequate. A definitive modality can be sufficient by itself in the named scenarios. A topical agent can be considered as rescue for persistent bleeding, with repeat endoscopic treatment for clinical rebleeding when appropriate. Consider transcatheter arterial embolisation if endoscopic treatment fails, and surgery if embolisation is unavailable or unsuccessful.

Timing and acid suppression

For nonvariceal upper GI bleeding requiring hospital care, aim for OGD within 24 hours of presentation after resuscitation. ESGE 2026 advises against routine endoscopy within six or 12 hours except when instability persists despite adequate resuscitation. The variceal pathway has its own timing.

Following endoscopic haemostasis of a high-risk ulcer, give high-dose PPI. One regimen is an 80 mg IV bolus followed by 8 mg/hour IV for 72 hours. Guideline alternatives include high-dose intermittent IV or oral dosing. Reducing acid helps stabilise clot. ESGE 2026 suggests considering high-dose IV PPI before endoscopy, provided it does not delay endoscopy. NICE CG141 advises against routine acid suppression before endoscopy in suspected nonvariceal bleeding. These recommendations differ before haemostasis.

Test for H. pylori during the index admission, eradicate infection if present and confirm eradication. A negative test during acute bleeding can miss infection and should be repeated. Review the indication for NSAIDs and any antithrombotic decisions with the relevant team.

ESGE 2026 peptic ulcer guideline and algorithm · NICE CG141 nonvariceal bleeding

Start treatment for suspected acute variceal bleeding

Cirrhosis and portal hypertension increase the chance that an acute upper GI bleed is variceal. A hepatic venous pressure gradient (HVPG) of at least 10 mmHg defines clinically significant portal hypertension in alcohol-related or viral cirrhosis. Varices are collateral veins that develop as portal blood is diverted into the systemic circulation. In cirrhosis with haematemesis, begin haemodynamic assessment and specific therapy while arranging endoscopy.

  1. Vasoactive treatment. Start terlipressin, octreotide or somatostatin promptly when variceal bleeding is suspected. These drugs lower portal inflow. Baveno VII recommends a 2–5 day course of vasoactive treatment. The Irish Glypressin 1 mg/8.5 mL injection SmPC gives an initial 2 mg terlipressin acetate IV every four hours for adult bleeding oesophageal varices, until bleeding has been controlled for 24 hours and up to 48 hours. The label permits dose reduction in specific circumstances. Use the product-specific instructions and local protocol. Monitor for ischaemia and sodium changes with terlipressin. An octreotide regimen in AASLD guidance is 50 micrograms IV initially, then 25–50 micrograms/hour.
  2. Antibiotic prophylaxis. Start it on admission for patients with cirrhosis and upper GI bleeding. For acute variceal haemorrhage in advanced chronic liver disease, ESGE recommends ceftriaxone 1 g IV daily for up to seven days, adjusted for allergy, local resistance and prescribing policy.
  3. Endoscopy. Aim for OGD within 12 hours of presentation after haemodynamic resuscitation. When instability persists, proceed as soon as it can be done safely. Altered consciousness or active vomiting of blood may require intubation before endoscopy. Use band ligation for bleeding oesophageal varices. For cardiofundal GOV2 and IGV1 varices, ESGE recommends cyanoacrylate injection by an appropriately skilled team. GOV1 can be treated with cyanoacrylate or band ligation depending on the case.

Select pre-emptive or salvage TIPS

A transjugular intrahepatic portosystemic shunt (TIPS) reduces portal pressure by connecting the portal and hepatic venous circulations. Seek early hepatology and interventional radiology input after haemostasis for patients at high risk of treatment failure. In Baveno VII, pre-emptive covered TIPS within 72 hours, ideally within 24 hours, is indicated for bleeding oesophageal or type 1/2 gastro-oesophageal varices with Child-Pugh C below 14, Child-Pugh B above 7 and active bleeding on initial endoscopy, or HVPG above 20 mmHg at bleeding. EASL 2025 defines the HVPG high-risk threshold as at least 20 mmHg and states the high-risk criteria for oesophageal or type 1 gastro-oesophageal varices. Cardiofundal bleeding requires specialist selection of the intervention.

If combined drug and endoscopic treatment fails, seek salvage covered TIPS. A covered self-expanding oesophageal stent, or balloon tamponade when appropriate, can bridge refractory oesophageal haemorrhage to definitive treatment. Balloon tamponade needs an experienced team, airway protection, position confirmation and critical care monitoring. Use device-specific volumes and pressures and minimise the duration because of aspiration, migration and tissue injury risk.

Baveno VII, sections 1 and 6 · ESGE variceal bleeding guidance · Irish HPRA Glypressin SmPC · AASLD portal hypertension guidance · EASL TIPS guidance

Recognise causes of acute lower GI bleeding

CauseClinical reasoning
Diverticular haemorrhageOften sudden, painless haematochezia, sometimes large in volume. Bleeding arises from a vessel associated with a diverticulum. It can settle spontaneously or recur.
AngiodysplasiaFragile vascular ectasias can cause intermittent painless bleeding and iron deficiency. In Heyde syndrome, aortic stenosis is associated with GI angiodysplasia and loss of high-molecular-weight von Willebrand factor multimers.
Ischaemic colitisCrampy abdominal pain followed by urgent passage of bloody stool suggests colonic ischaemia, particularly with vascular disease or low-flow states. Watershed regions such as the splenic flexure and rectosigmoid junction can be involved. Contrast CT helps assess the distribution and severity. Severe pain with little bleeding should also raise concern for acute mesenteric ischaemia.
Colorectal neoplasiaPersistent bleeding, iron deficiency, altered bowel habit or weight loss warrant investigation for malignancy. A haemorrhoid does not explain away these findings.
Haemorrhoids and anal fissureFresh blood on tissue or coating the stool can come from an anorectal source. Sharp pain during or after defecation suggests a fissure.

Choose an investigation by bleeding severity

  • Minor, self-limited bleed with no adverse features. Use clinical assessment and, if appropriate, the Oakland score. It considers age, sex, prior lower GI bleeding admission, digital rectal blood, heart rate, systolic BP and haemoglobin. A score ≤8 supports discharge for outpatient investigation if no other reason for admission exists.
  • Stable patient admitted with a major bleed. Arrange appropriately prepared inpatient colonoscopy. ESGE recommends colonoscopy during the hospital stay. ACG recommends nonurgent inpatient colonoscopy for most patients, because a routine procedure within 24 hours has not improved important clinical outcomes. Endoscopic therapy depends on the identified lesion and bleeding stigma.
  • Haemodynamic instability and suspected ongoing lower GI bleeding. Resuscitate and obtain urgent CT angiography (CTA) if feasible. Call interventional radiology promptly if CTA shows active extravasation, to assess for angiography and possible selective embolisation. Consider an upper source from the start. In the BSG pathway, unstable haematochezia with no lower source on initial CTA warrants immediate upper endoscopy. If the history instead strongly points to upper bleeding, involve the upper GI team urgently. Nasogastric aspirate is insufficient to rule out an upper source.

Worked example. Heart rate 114/min divided by systolic BP 89 mmHg gives a shock index of about 1.28. With continued haematochezia, this is an unstable bleeding pathway. Resuscitate and localise the active bleed rapidly. The Oakland low-risk discharge threshold is inappropriate in this setting.

ESGE acute lower GI bleeding · BSG acute lower GI bleeding recommendations · ACG 2023 acute lower GI bleeding guideline · ACG colon ischaemia guideline · Primary study of von Willebrand factor in aortic stenosis

Loading diagram...
Clinical Decision Algorithm for Acute Gastrointestinal Haemorrhage
Test Your Knowledge

A 58-year-old man with alcohol-related cirrhosis and portal hypertension presents to the emergency department with haematemesis and dizziness. On examination, he is pale and clammy. His blood pressure is 88/54 mmHg, heart rate is 114 bpm, respiratory rate is 20 breaths/min, and oxygen saturation is 97% on room air. Abdominal examination reveals mild ascites and spider naevi. Urgent blood tests reveal: haemoglobin 74 g/L, platelets 68 x 10^9/L, INR 1.4, blood urea 14.2 mmol/L, and creatinine 82 mcmol/L. Two 14-gauge intravenous lines are secured, and 500 mL of balanced crystalloid is infused. Which treatment plan should be initiated now?

A

Start IV vasoactive therapy and antibiotic prophylaxis for suspected variceal bleeding, continue perfusion-guided resuscitation, and arrange urgent endoscopy

B

Transfuse two units of packed red blood cells immediately to achieve a target haemoglobin greater than 100 g/L

C

Administer oral propranolol 40 mg twice daily and arrange elective outpatient oesophagogastroduodenoscopy within one week

D

Administer intravenous omeprazole 80 mg bolus and transfuse two adult doses of pooled platelets to correct thrombocytopenia

Test Your Knowledge

A 64-year-old woman presents to the acute medical unit following two episodes of melaena and light-headedness. She has a history of osteoarthritis for which she takes naproxen regularly. Following initial crystalloid resuscitation, her blood pressure is 122/76 mmHg and heart rate is 78 bpm. Urgent upper endoscopy (OGD) performed 8 hours after admission reveals a 15-mm benign-appearing ulcer on the posterior duodenal bulb with a pigmented, non-bleeding protuberance in the centre of the ulcer base (Forrest Class IIa). No active spurting is seen. What is the most appropriate endoscopic and pharmacological management strategy?

A

Perform endoscopic adrenaline injection monotherapy and transfer the patient to a general ward on oral omeprazole 20 mg once daily

B

Defer endoscopic intervention because the vessel is not actively bleeding, and initiate oral sucralfate suspension

C

Clip or thermally treat the visible vessel, with dilute adrenaline as an optional adjunct, then give high-dose PPI therapy

D

Refer immediately for emergency laparotomy and surgical duodenotomy with vessel under-running

Test Your Knowledge

A 76-year-old man with a background of hypertension, ischaemic cardiomyopathy, and peripheral vascular disease is brought by ambulance to the resuscitation bay following the sudden passage of voluminous, dark red blood and clots per rectum. On arrival, he is confused and diaphoretic. His blood pressure is 78/46 mmHg, heart rate is 126 bpm, and respiratory rate is 24 breaths/min. Abdominal palpation reveals a soft, non-distended abdomen without tenderness. Digital rectal examination reveals copious fresh blood. His blood pressure remains 84/50 mmHg after initial resuscitation, and he continues to pass blood. The team activates its major haemorrhage pathway. There is no haematemesis or known portal hypertension. What is the most appropriate next diagnostic and therapeutic step?

A

Administer 4 litres of polyethylene glycol bowel preparation solution via a nasogastric tube to prepare for emergency colonoscopy in 4 hours

B

Arrange immediate CT angiography while resuscitation continues. If CTA shows active bleeding, involve interventional radiology for angiography and possible embolisation.

C

Perform immediate rigid sigmoidoscopy with rubber band ligation of internal haemorrhoids

D

Initiate intravenous terlipressin and request emergency barium enema fluoroscopy

Sections you finish are checked off in the contents.